Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

RAS INHIBITION

Ace-ylation in the hole

Mutant-selective KRAS-targeting drugs hold great promise for the treatment of some of the most aggressive forms of cancer. Building on the breakthrough success of KRAS-G12C inhibitors, researchers have now found a way to target another mutant KRAS with serine-modifying covalent inhibitors.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Targeting KRAS-G12S with covalent inhibitors that react with a non-catalytic serine.

References

  1. Zhang, Z., Guiley, K. Z. & Shokat, K. M. Nat. Chem. Biol. https://doi.org/10.1038/s41589-022-01065-9 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Moore, A. R. et al. Nat. Rev. Drug Discov. 19, 533–552 (2020).

    CAS  Article  Google Scholar 

  3. Ostrem, J. M. et al. Nature 503, 548–551 (2013).

    CAS  Article  Google Scholar 

  4. Dodson, G. & Wlodawer, A. Trends Biochem. Sci. 23, 347–352 (1998).

    CAS  Article  Google Scholar 

  5. Bachovchin, D. A. & Cravatt, B. F. Nat. Rev. Drug. Discov. 11, 52–68 (2012).

    CAS  Article  Google Scholar 

  6. Robinson, S. L. et al. Nat. Prod. Rep. 36, 458–475 (2019).

    CAS  Article  Google Scholar 

  7. Fell, J. B. et al. J. Med. Chem. 63, 6679–6693 (2020).

    CAS  Article  Google Scholar 

  8. Skoulidis, F. et al. N. Engl. J. Med. 384, 2371–2381 (2021).

    CAS  Article  Google Scholar 

  9. Wang, X. et al. J. Med. Chem. 65, 3123–3133 (2022).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Micah J. Niphakis or Benjamin F. Cravatt.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

J. Niphakis, M., F. Cravatt, B. Ace-ylation in the hole. Nat Chem Biol (2022). https://doi.org/10.1038/s41589-022-01083-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41589-022-01083-7

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer